Unit
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Mind the sump! - diagnostic challenge of a rare complication of choledochoduodenostomy
Zeuge U, Fehr M, Meyenberger C, Sulz M. Mind the sump! - diagnostic challenge of a rare complication of choledochoduodenostomy. Case Rep Gastroenterol 2014; 8:358-63.
Nov 13, 2014Mind the sump! - diagnostic challenge of a rare complication of choledochoduodenostomy
Nov 13, 2014Case Rep Gastroenterol 2014; 8:358-63
Zeuge Ulf, Fehr Martin, Meyenberger Christa, Sulz Michael
Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs
Tibau A, Barnadas A, Seruga B, Ocana A, Templeton A, Vera-Badillo F, Ethier J, Srikanthan A, Bedard P, Amir E. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs. J Clin Oncol 2014; 33:100-6.
Nov 10, 2014Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs
Nov 10, 2014J Clin Oncol 2014; 33:100-6
Tibau Ariadna, Barnadas Agustí, Seruga Bostjan, Ocana Alberto, Templeton Arnoud, Vera-Badillo Francisco E, Ethier Josee-Lyne, Srikanthan Amirrtha, Bedard Philippe L, Amir Eitan
Personalizing, not patronizing: The case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
Oldenburg J, Gillessen Sommer S, Haugnes H, Honecker F, Horwich A, Lorch A, Ondruscaron D, Rosti G, Stephenson A, Germà-Lluch J, Fossa S, Aparicio J, Beyer J, Cohn-Cedermark G, Cullen M, Gilligan T, De Giorgi U, De Santis M, De Wit R, Tandstad T. Personalizing, not patronizing: The case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Ann Oncol 2014
Nov 6, 2014Personalizing, not patronizing: The case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
Nov 6, 2014Ann Oncol 2014
Oldenburg J, Gillessen Sommer Silke, Haugnes H S, Honecker F, Horwich A, Lorch A, Ondruscaron D, Rosti G, Stephenson A, Germà-Lluch J R, Fossa S D, Aparicio J, Beyer J, Cohn-Cedermark G, Cullen M, Gilligan T, De Giorgi U, De Santis M, De Wit R, Tandstad T
PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate
Ferraldeschi R, Sideris S, Bianchini D, Grist E, Thway K, Perez Lopez R, Tunariu N, Parker C, Dearnaley D, Reid A, Attard G, Altavilla A, Mateo J, Nava Rodrigues D, Riisnaes R, Miranda S, Figueiredo I, Rescigno P, Ravi P, Pezaro C, Omlin A, Lorente D, Zafeiriou Z, de Bono J. PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate. Eur Urol 2014
Nov 4, 2014PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate
Nov 4, 2014Eur Urol 2014
Ferraldeschi Roberta, Sideris Spyridon, Bianchini Diletta, Grist Emily, Thway Khin, Perez Lopez Raquel, Tunariu Nina, Parker Chris, Dearnaley David, Reid Alison, Attard Gerhardt, Altavilla Amelia, Mateo Joaquin, Nava Rodrigues Daniel, Riisnaes Ruth, Miranda Susana, Figueiredo Ines, Rescigno Pasquale, Ravi Praful, Pezaro Carmel, Omlin Aurelius, Lorente David, Zafeiriou Zafeiris, de Bono Johann
Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients: A Population-Based, Propensity Score-Adjusted Trend Analysis
Tarantino I, Warschkow R, Worni M, Cerny T, Ulrich A, Schmied B, Gueller U. Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients: A Population-Based, Propensity Score-Adjusted Trend Analysis. Ann Surg 2014; 262:112-120.
Nov 4, 2014Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients: A Population-Based, Propensity Score-Adjusted Trend Analysis
Nov 4, 2014Ann Surg 2014; 262:112-120
Tarantino Ignazio, Warschkow Rene, Worni Mathias, Cerny Thomas, Ulrich Alexis, Schmied Bruno, Gueller Ulrich
Mind the Sump! - Diagnostic Challenge of a Rare Complication of Choledochoduodenostomy
Zeuge U, Fehr M, Meyenberger C, Sulz M. Mind the Sump! - Diagnostic Challenge of a Rare Complication of Choledochoduodenostomy. Case Reports in Gastroentrerology 2014; 8:358-363.
Nov 1, 2014Mind the Sump! - Diagnostic Challenge of a Rare Complication of Choledochoduodenostomy
Nov 1, 2014Case Reports in Gastroentrerology 2014; 8:358-363
Zeuge Ulf, Fehr Martin, Meyenberger Christa, Sulz Michael
Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA
Krop I, Welslau M, Samant M, Miles D, Lu M, Huober J, Guardino E, Blackwell K, Lin N, Diéras V. Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA. Ann Oncol 2014; 26:113-119.
Oct 29, 2014Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA
Oct 29, 2014Ann Oncol 2014; 26:113-119
Krop I E, Welslau M, Samant M, Miles D, Lu M, Huober Jens, Guardino E, Blackwell K, Lin N U, Diéras V
Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy
Lindner J, Tesch H, Karn T, Pommerenke F, Liedtke C, Untch M, Müller V, Rack B, Schem C, Engels K, Huober J, Sinn B, Loibl S, Denkert C, Ataseven B, Fasching P, Pfitzner B, Gerber B, Gade S, Darb-Esfahani S, von Minckwitz G. Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy. Ann Oncol 2014; 26:95-100.
Oct 29, 2014Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy
Oct 29, 2014Ann Oncol 2014; 26:95-100
Lindner J L, Tesch H, Karn T, Pommerenke F, Liedtke C, Untch M, Müller V, Rack B, Schem C, Engels K, Huober Jens, Sinn B V, Loibl S, Denkert C, Ataseven B, Fasching P A, Pfitzner B M, Gerber B, Gade S, Darb-Esfahani S, von Minckwitz G
Use and misuse of waterfall plots
Shao T, Shoushtari H, Sinaei M, Kim T, Margolis M, McNamara M, Vera-Badillo F, Jang R, Templeton A, Wang L, Tannock I. Use and misuse of waterfall plots. J Natl Cancer Inst 2014; 106
Oct 29, 2014Use and misuse of waterfall plots
Oct 29, 2014J Natl Cancer Inst 2014; 106
Shao Tiffany, Shoushtari Hassan, Sinaei Mehrdad, Kim Tae Kyoung, Margolis Myles, McNamara Mairead G, Vera-Badillo Francisco W, Jang Raymond, Templeton Arnoud, Wang Lisa, Tannock Ian F
The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case-control studies
Ruan X, Seeger H, Wallwiener D, Huober J, Mueck A. The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case-control studies. Arch Gynecol Obstet 2014; 291:1141-6.
Oct 16, 2014The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case-control studies
Oct 16, 2014Arch Gynecol Obstet 2014; 291:1141-6
Ruan Xiangyan, Seeger Harald, Wallwiener Diethelm, Huober Jens, Mueck Alfred O
Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone
Lorente D, de Bono J, Gillessen Sommer S, Dearnaley D, Parker C, Tunariu N, Zafeirou Z, Altavilla A, Mateo J, Perez R, Pezaro C, Ferraldeschi R, Omlin A, Attard G. Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone. Br J Cancer 2014
Oct 14, 2014Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone
Oct 14, 2014Br J Cancer 2014
Lorente D, de Bono J, Gillessen Sommer Silke, Dearnaley D, Parker C, Tunariu N, Zafeirou Z, Altavilla A, Mateo J, Perez R, Pezaro C, Ferraldeschi R, Omlin Aurelius, Attard G
Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors
Tornatore L, Dyson J, Walker B, Leonardi A, Chambery A, Driessen C, Sonneveld P, Morgan G, Palumbo A, Tramontano A, Rahemtulla A, Ruvo M, Thotakura A, Jaxa-Chamiec A, Sandomenico A, Raimondo D, Low C, Rocci A, Tralau-Stewart C, Capece D, D'Andrea D, Bua M, Boyle E, van Duin M, Zoppoli P, Franzoso G. Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors. Cancer Cell 2014; 26:495-508.
Oct 13, 2014Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors
Oct 13, 2014Cancer Cell 2014; 26:495-508
Tornatore Laura, Dyson Julian, Walker Brian A, Leonardi Antonio, Chambery Angela, Driessen Christoph, Sonneveld Pieter, Morgan Gareth, Palumbo Antonio, Tramontano Anna, Rahemtulla Amin, Ruvo Menotti, Thotakura Anil K, Jaxa-Chamiec Albert, Sandomenico Annamaria, Raimondo Domenico, Low Caroline, Rocci Alberto, Tralau-Stewart Cathy, Capece Daria, D'Andrea Daniel, Bua Marco, Boyle Eileen, van Duin Mark, Zoppoli Pietro, Franzoso Guido
Regulation of endothelial permeability in the primate corpora lutea: implications for ovarian hyperstimulation syndrome
Herr D, Bekes I, Wulff C. Regulation of endothelial permeability in the primate corpora lutea: implications for ovarian hyperstimulation syndrome. Reproduction 2014; 149:R71-9.
Oct 9, 2014Regulation of endothelial permeability in the primate corpora lutea: implications for ovarian hyperstimulation syndrome
Oct 9, 2014Reproduction 2014; 149:R71-9
Herr Daniel, Bekes Inga, Wulff Christine
Detection of Intraneural Ganglia With Nerve Sonography as a Cause for Painful Peroneal Palsy: a Case Series and Review of the Literature
Felbecker A, Schilg-Hafer L, Hägele-Link S, Gers B, Weber J, Tettenborn B, Hundsberger T (2014). Detection of Intraneural Ganglia With Nerve Sonography as a Cause for Painful Peroneal Palsy: a Case Series and Review of the Literature.
Oct 7, 2014Detection of Intraneural Ganglia With Nerve Sonography as a Cause for Painful Peroneal Palsy: a Case Series and Review of the Literature
Oct 7, 2014Jahrestagung SNG 2014
Felbecker Ansgar, Schilg-Hafer Lenka, Hägele-Link Stefan, Gers Bettina, Weber Johannes, Tettenborn Barbara, Hundsberger Thomas
Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer
Leibowitz-Amit R, Templeton A, Alibhai S, Knox J, Sridhar S, Tannock I, Joshua A. Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer. J Geriatr Oncol 2014; 6:23-8.
Oct 7, 2014Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer
Oct 7, 2014J Geriatr Oncol 2014; 6:23-8
Leibowitz-Amit Raya, Templeton Arnoud, Alibhai Shabbir M, Knox Jennifer J, Sridhar Srikala S, Tannock Ian F, Joshua Anthony M
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
Sebastian M, Gnad-Vogt U, Kallen K, Heidenreich R, Fotin-Mleczek M, Scheel B, Koch S, Rippin G, Wehler T, Hilbe W, Cathomas R, Früh M, Weiss C, Papachristofilou A, Zippelius A. Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer. BMC cancer 2014; 14:748.
Oct 6, 2014Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
Oct 6, 2014BMC cancer 2014; 14:748
Sebastian Martin, Gnad-Vogt Ulrike, Kallen Karl-Josef, Heidenreich Regina, Fotin-Mleczek Mariola, Scheel Birgit, Koch Sven D, Rippin Gerd, Wehler Thomas, Hilbe Wolfgang, Cathomas Richard, Früh Martin, Weiss Christian, Papachristofilou Alexandros, Zippelius Alfred
Adjuvant bisphosphonates in breast cancer treatment
Knauer M, Thürlimann B. Adjuvant bisphosphonates in breast cancer treatment. Breast Care (Basel) 2014; 9:319-22.
Oct 1, 2014Adjuvant bisphosphonates in breast cancer treatment
Oct 1, 2014Breast Care (Basel) 2014; 9:319-22
Knauer Michael, Thürlimann Beat
Bone targeted therapy in breast cancer - an old concept but still much to do
Huober J, Thürlimann B. Bone targeted therapy in breast cancer - an old concept but still much to do. Breast Care (Basel) 2014; 9:310.
Oct 1, 2014Bone targeted therapy in breast cancer - an old concept but still much to do
Oct 1, 2014Breast Care (Basel) 2014; 9:310
Huober Jens, Thürlimann Beat
Uncommon case of brain metastasis in a patient with a history of heavy smoking.
Scharl M, Bode B, Rushing E, Knuth A, Rordorf T. Uncommon case of brain metastasis in a patient with a history of heavy smoking. Curr Oncol 2014; 21:e728-31.
Oct 1, 2014Uncommon case of brain metastasis in a patient with a history of heavy smoking.
Oct 1, 2014Curr Oncol 2014; 21:e728-31
Scharl Michael, Bode B, Rushing Elisabeth Jane, Knuth A, Rordorf Tamara
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function
Slingerland M, Valera S, Waldron E, Mu S, Porro M, Loman N, Sandstrom P, Sharma S, Clive S, Hess D, Gelderblom H. A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function. Cancer Chemother Pharmacol 2014; 74:1089-98.
Sep 25, 2014A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function
Sep 25, 2014Cancer Chemother Pharmacol 2014; 74:1089-98
Slingerland Marije, Valera Sue-Zette, Waldron Edward, Mu Song, Porro Maria G, Loman Niklas, Sandstrom Per, Sharma Sunil, Clive Sally, Hess Dagmar, Gelderblom Hans